HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kosuke Hamai Selected Research
Kosuke Hamai Research Topics
Disease
10
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 09/2018
5
Lung Neoplasms (Lung Cancer)
01/2022 - 01/2020
4
Neoplasms (Cancer)
11/2023 - 01/2020
3
Hemorrhage
01/2022 - 08/2018
2
Adenocarcinoma
01/2023 - 01/2022
2
Asthma (Bronchial Asthma)
01/2022 - 07/2021
2
Venous Thromboembolism
01/2022 - 05/2021
2
Disease Progression
01/2021 - 01/2021
1
Febrile Neutropenia
01/2023
1
Interstitial Lung Diseases (Interstitial Lung Disease)
12/2022
1
COVID-19
05/2022
1
Respiratory Insufficiency (Respiratory Failure)
05/2022
1
Chronic Obstructive Pulmonary Disease (COPD)
07/2021
1
Carcinoma (Carcinomatosis)
01/2021
1
Ileus
11/2018
1
Osteonecrosis (Kienbock's Disease)
09/2018
1
Healthcare-Associated Pneumonia
08/2018
1
Bacterial Pneumonia
01/2016
1
Idiopathic Pulmonary Fibrosis
01/2016
Drug/Important Bio-Agent (IBA)
2
Tyrosine Kinase Inhibitors
IBA
11/2023 - 05/2021
2
Docetaxel (Taxotere)
FDA Link
01/2023 - 09/2018
2
Prothrombin (Factor II)
IBA
01/2023 - 01/2022
2
Anticoagulants
IBA
01/2022 - 05/2021
2
mepolizumab
IBA
01/2022 - 07/2021
2
edoxaban
IBA
01/2022 - 05/2021
2
Gefitinib (Iressa)
FDA Link
10/2021 - 05/2021
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
10/2021 - 05/2021
2
ErbB Receptors (EGF Receptor)
IBA
10/2021 - 05/2021
2
Pemetrexed (MTA)
FDA Link
01/2021 - 09/2018
1
Ramucirumab
IBA
01/2023
1
pegfilgrastim (Neulasta)
FDA Link
01/2023
1
Immune Checkpoint Inhibitors
IBA
12/2022
1
durvalumab
IBA
12/2022
1
capmatinib
IBA
06/2022
1
tepotinib
IBA
06/2022
1
baricitinib
IBA
05/2022
1
benralizumab
IBA
01/2022
1
pembrolizumab
IBA
01/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
07/2021
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
05/2021
1
Warfarin (Coumadin)
FDA Link
Generic
05/2021
1
Platinum
IBA
01/2021
1
Gemcitabine
FDA Link
01/2021
1
osimertinib
IBA
01/2021
1
Carboplatin (JM8)
FDA Link
Generic
01/2021
1
B7-H1 Antigen
IBA
01/2020
1
Bilirubin
IBA
11/2018
1
Bevacizumab (Avastin)
FDA Link
09/2018
1
Serum Albumin
IBA
08/2018
1
Proton Pump Inhibitors
IBA
08/2018
1
Ligands
IBA
01/2016
1
Matrix Metalloproteinase 7 (Matrilysin)
IBA
01/2016
1
Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)
IBA
01/2016
1
CC Chemokines
IBA
01/2016
Therapy/Procedure
6
Therapeutics
11/2023 - 01/2020
3
Drug Therapy (Chemotherapy)
01/2021 - 09/2018
2
Drug Tapering
01/2023 - 10/2021
1
Chemoradiotherapy
12/2022
1
Enteral Nutrition (Feeding, Tube)
08/2018